PAI-1 antagonists: Predictable indications and unconventional applications

Keyphrases

• ACE Inhibitors 20%
• Amyloidosis 20%
• Direct Way 20%
• Fibrinolytic Activity 40%
• Fibrinolytic System 40%
• Hormone Replacement Therapy 20%
• Human Disease 20%
• Insulin Sensitizers 20%
• Long-term Administration 20%
• Obesity 20%
• Plasma Parameters 20%
• Plasminogen Activator inhibitor-1 (PAI-1) 100%
• Polycystic Ovary Syndrome 20%
• Therapeutic Potential 20%
• Thrombolytic Agents 20%
• Thrombotic 20%
• Thrombotic Events 20%
• Type 2 Diabetes Mellitus (T2DM) 20%
• Unconventional Applications 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Amyloidosis 20%
• Dipeptidyl Carboxypeptidase Inhibitor 20%
• Disease 20%
• Fibrinolytic Agent 100%
• Insulin Sensitizing Agent 20%
• Non Insulin Dependent Diabetes Mellitus 20%
• Plasminogen Activator Inhibitor 1 100%
• Replacement Therapy 20%
• Syndrome 20%
• Thrombosis 20%

Medicine and Dentistry

• ACE Inhibitor 20%
• Amyloidosis 20%
• Diseases 20%
• Fibrinolysis 80%
• Hormone Substitution 20%
• Insulin Sensitizing Agent 20%
• Maturity Onset Diabetes of the Young 20%
• Plasminogen Activator Inhibitor-1 100%
• Polycystic Ovarian Syndrome 20%
• Thrombolytic Drug 20%
• Thrombosis 20%